Cardiometabolic risk factors in the Swedish Werlabs cohort based on self-initiated health screening: cohort profile

Purpose There is limited research on individuals undergoing self-initiated health examinations, and the Werlabs cohort will be a base for such research.Participants All individuals aged 18 or older who had undertaken a self-initiated health examination at Werlabs AB with at least one recorded value...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter Ueda, Kerstin Brismar, Anna Norhammar, Daniel Peter Andersson, Hannah Coudé Adam, Omid Hajimirsadeghi, Lovisa Krantz, Nadia Bandstein Forsberg
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/1/e093625.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595946497638400
author Peter Ueda
Kerstin Brismar
Anna Norhammar
Daniel Peter Andersson
Hannah Coudé Adam
Omid Hajimirsadeghi
Lovisa Krantz
Nadia Bandstein Forsberg
author_facet Peter Ueda
Kerstin Brismar
Anna Norhammar
Daniel Peter Andersson
Hannah Coudé Adam
Omid Hajimirsadeghi
Lovisa Krantz
Nadia Bandstein Forsberg
author_sort Peter Ueda
collection DOAJ
description Purpose There is limited research on individuals undergoing self-initiated health examinations, and the Werlabs cohort will be a base for such research.Participants All individuals aged 18 or older who had undertaken a self-initiated health examination at Werlabs AB with at least one recorded value of creatinine or cholesterol in Sweden (from 1 January 2015 through 31 December 2023) was included. Medical history and anthropometric measurements were self-reported through an online questionnaire. We describe cohort baseline characteristics, demographic variables and cardiometabolic risk factors.Findings to date The study population includes 149 556 individuals who provided at least one health screening. The median (IQR) age was 43 (33–54) years and 54% were women. The most common self-reported chronic disease was hypertension (4.5%), followed by cardiovascular disease (0.9%) and 12.6% reported values of obesity. The prevalence was 2.1% for diabetes, 1.2% for kidney disease (including an estimated glomerular filtration rate of <60 mL/min/1.73 m2), 57.8% for a low-density lipoprotein cholesterol level of >3.0 mmol/L and 4.1% for anaemia (haemoglobin <120 g/L and <130 g/L for women and men, respectively). Interestingly, 1.5% of the individuals had a glucose measurement of >7.0 mmol/L, without reporting a previous diagnosis of diabetes. In an analysis restricted to 621 individuals with recorded blood pressure data between the age of 40 and 70 years and without existing cardiovascular disease, diabetes or kidney disease, 35,4% were classified as high or very high cardiovascular risk according to the 2021 ESC guidelines on cardiovascular disease prevention and with lipid levels that made them eligible for lipid-lowering therapy.Future plans The Werlabs cohort comprises a rather healthy and young population that can provide opportunities for future studies on individuals undergoing self-initiated health examinations and has the potential to impact treatment of cardiometabolic risk factors.
format Article
id doaj-art-410a462ee555441c831ad36780e9977b
institution Kabale University
issn 2044-6055
language English
publishDate 2025-01-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-410a462ee555441c831ad36780e9977b2025-01-17T23:35:09ZengBMJ Publishing GroupBMJ Open2044-60552025-01-0115110.1136/bmjopen-2024-093625Cardiometabolic risk factors in the Swedish Werlabs cohort based on self-initiated health screening: cohort profilePeter Ueda0Kerstin Brismar1Anna Norhammar2Daniel Peter Andersson3Hannah Coudé Adam4Omid Hajimirsadeghi5Lovisa Krantz6Nadia Bandstein Forsberg73 Freelance Researcher, Stockholm, Sweden2 Karolinska Institutet, Stockholm, Sweden2 Karolinska Institutet, Stockholm, Sweden1 Werlabs AB, Stockholm, Sweden1 Werlabs AB, Stockholm, Sweden1 Werlabs AB, Stockholm, Sweden1 Werlabs AB, Stockholm, Sweden1 Werlabs AB, Stockholm, SwedenPurpose There is limited research on individuals undergoing self-initiated health examinations, and the Werlabs cohort will be a base for such research.Participants All individuals aged 18 or older who had undertaken a self-initiated health examination at Werlabs AB with at least one recorded value of creatinine or cholesterol in Sweden (from 1 January 2015 through 31 December 2023) was included. Medical history and anthropometric measurements were self-reported through an online questionnaire. We describe cohort baseline characteristics, demographic variables and cardiometabolic risk factors.Findings to date The study population includes 149 556 individuals who provided at least one health screening. The median (IQR) age was 43 (33–54) years and 54% were women. The most common self-reported chronic disease was hypertension (4.5%), followed by cardiovascular disease (0.9%) and 12.6% reported values of obesity. The prevalence was 2.1% for diabetes, 1.2% for kidney disease (including an estimated glomerular filtration rate of <60 mL/min/1.73 m2), 57.8% for a low-density lipoprotein cholesterol level of >3.0 mmol/L and 4.1% for anaemia (haemoglobin <120 g/L and <130 g/L for women and men, respectively). Interestingly, 1.5% of the individuals had a glucose measurement of >7.0 mmol/L, without reporting a previous diagnosis of diabetes. In an analysis restricted to 621 individuals with recorded blood pressure data between the age of 40 and 70 years and without existing cardiovascular disease, diabetes or kidney disease, 35,4% were classified as high or very high cardiovascular risk according to the 2021 ESC guidelines on cardiovascular disease prevention and with lipid levels that made them eligible for lipid-lowering therapy.Future plans The Werlabs cohort comprises a rather healthy and young population that can provide opportunities for future studies on individuals undergoing self-initiated health examinations and has the potential to impact treatment of cardiometabolic risk factors.https://bmjopen.bmj.com/content/15/1/e093625.full
spellingShingle Peter Ueda
Kerstin Brismar
Anna Norhammar
Daniel Peter Andersson
Hannah Coudé Adam
Omid Hajimirsadeghi
Lovisa Krantz
Nadia Bandstein Forsberg
Cardiometabolic risk factors in the Swedish Werlabs cohort based on self-initiated health screening: cohort profile
BMJ Open
title Cardiometabolic risk factors in the Swedish Werlabs cohort based on self-initiated health screening: cohort profile
title_full Cardiometabolic risk factors in the Swedish Werlabs cohort based on self-initiated health screening: cohort profile
title_fullStr Cardiometabolic risk factors in the Swedish Werlabs cohort based on self-initiated health screening: cohort profile
title_full_unstemmed Cardiometabolic risk factors in the Swedish Werlabs cohort based on self-initiated health screening: cohort profile
title_short Cardiometabolic risk factors in the Swedish Werlabs cohort based on self-initiated health screening: cohort profile
title_sort cardiometabolic risk factors in the swedish werlabs cohort based on self initiated health screening cohort profile
url https://bmjopen.bmj.com/content/15/1/e093625.full
work_keys_str_mv AT peterueda cardiometabolicriskfactorsintheswedishwerlabscohortbasedonselfinitiatedhealthscreeningcohortprofile
AT kerstinbrismar cardiometabolicriskfactorsintheswedishwerlabscohortbasedonselfinitiatedhealthscreeningcohortprofile
AT annanorhammar cardiometabolicriskfactorsintheswedishwerlabscohortbasedonselfinitiatedhealthscreeningcohortprofile
AT danielpeterandersson cardiometabolicriskfactorsintheswedishwerlabscohortbasedonselfinitiatedhealthscreeningcohortprofile
AT hannahcoudeadam cardiometabolicriskfactorsintheswedishwerlabscohortbasedonselfinitiatedhealthscreeningcohortprofile
AT omidhajimirsadeghi cardiometabolicriskfactorsintheswedishwerlabscohortbasedonselfinitiatedhealthscreeningcohortprofile
AT lovisakrantz cardiometabolicriskfactorsintheswedishwerlabscohortbasedonselfinitiatedhealthscreeningcohortprofile
AT nadiabandsteinforsberg cardiometabolicriskfactorsintheswedishwerlabscohortbasedonselfinitiatedhealthscreeningcohortprofile